Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate efficacy and safety of quetiapine fumarate
(SEROQUEL) compared with placebo in the treatment of adolescent patients with schizophrenia.